SEC Form SC 13G/A filed

2/10/21 4:06:01 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $NATR alert in real time by email

SC 13G/A 1 natr13gafeb102021.txt SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G (Rule 13d-102) (Amendment No. 7) NATURE'S SUNSHINE PRODUCTS, INC. (Name of Issuer) Common Stock 639027101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP NO. 639027101 Page 2 of 4 Pages 1) Name of Reporting Person(s) I.R.S. Identification No. of Above Person (entities only) Paradigm Capital Management, Inc. 14-1770168 ----------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (a)_____ (b)_____ Not Applicable ----------------------------------------------------------------------------- 3) SEC Use Only ----------------------------------------------------------------------------- 4) Citizenship or Place of Organization New York ----------------------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH (5) Sole Voting Power 1,150,087 (6) Shared Voting Power -0- (7) Sole Dispositive Power 1,150,087 (8) Shared Dispositive Power -0- ----------------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,150,087 ----------------------------------------------------------------------------- 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares Not Applicable ----------------------------------------------------------------------------- 11) Percent of Class Represented by Amount In Row (9) 5.85% ----------------------------------------------------------------------------- 12) Type of Reporting Person IA ----------------------------------------------------------------------------- CUSIP NO. 639027101 Page 3 of 4 Pages Item 1(a) Name of Issuer: NATURE'S SUNSHINE PRODUCTS, INC. Item 1(b) Address of Issuer's Principal Executive Offices: 2901 Bluegrass Boulevard, Suite 100 Lehi, Utah 84043 Item 2(a) Name of Person Filing: Paradigm Capital Management, Inc. Item 2(b) Address of Principal Business Office: Nine Elk Street, Albany, New York 12207 Item 2(c) Citizenship: A New York State Corporation Item 2(d) Title of Class of Securities: Common Stock Item 2(e) Cusip Number: 639027101 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d- (b) or 9c), check whether the person filing is a: (e) [X] an investment adviser in accordance with 240.13d-1(b) (1)(ii)(E). Item 4. Ownership. (a) Amount beneficially owned: 1,150,087 (b) Percent of class: 5.85% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 1,150,087 (ii) Shared power to vote or direct the vote: -0- (iii) Sole power to dispose or to direct the disposition of: 1,150,087 (iv) Shared power to dispose or to direct the disposition of: -0- CUSIP NO. 639027101 Page 4 of 4 Pages Item 5. Ownership of 5% or Less of a Class. If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of more than 5% on Behalf of Another Person. All securities reported in this Schedule 13G Report are owned by advisory clients of the Reporting Person. Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable Item 8 Identification and Classification of Members of the Group. Not Applicable Item 9 Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I (we) certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my (our) knowledge and belief, I (we) certify that the information set forth in this statement is true, complete and correct. Dated: February 10, 2021 PARADIGM CAPITAL MANAGEMENT, INC. By /s/ Thomas H. Signor Thomas H. Signor, Chief Compliance Officer Telephone: (518) 431-3500 - 4 -

Get the next $NATR alert in real time by email

Date

Price Target

Rating

Analyst

9/13/2024

$18.00

Buy

Canaccord Genuity

3/9/2022

$24.00 → $24.50

Buy

DA Davidson

11/5/2021

$22.00 → $24.00

Buy

DA Davidson

10/15/2021

$22.00

Buy

DA Davidson

SEC Form SC 13G/A filed

Chat with this insight

Recent Analyst Ratings for $NATR

$NATR Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Canaccord Genuity initiated coverage on Nature's Sunshine with a new price target

DA Davidson reiterated coverage on Natures Sunshine Products with a new price target

DA Davidson reiterated coverage on Natures Sunshine Products with a new price target

$NATR Press Releases

Fastest customizable press release news feed in the world

Nature's Sunshine Appoints Steven Fasching to Board of Directors

Nature's Sunshine Reports Third Quarter 2024 Results

Nature's Sunshine Sets Third Quarter 2024 Conference Call for Thursday, November 7, 2024, at 5:00 p.m. ET

$NATR Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Fasching Steven J. was granted 2,869 shares (SEC Form 4)

SEC Form 3 filed by new insider Fasching Steven J.

Large owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sold $29,946 worth of shares (2,300 units at $13.02) (SEC Form 4)

$NATR Market Insights

Live Market Insights

$NATR Large Ownership Changes

This live feed shows all institutional transactions in real time.

$NATR SEC Filings

$NATR Financials

Live finance-specific insights

$NATR Leadership Updates

Live Leadership Updates

Nature's Sunshine shares are trading lower after the company reported worse-than-expected Q1 financial results.

Natures Sunshine Products Sees FY24 Net Sales $455M-$480M Vs $467.900M Est.

Natures Sunshine Products Q1 2024 Adj EPS $0.12 Misses $0.17 Estimate, Sales $110.993M Miss $111.200M Estimate